Healthcare and Life Science
Tagomics publishes a new approach to genome-wide epigenomic profiling
Study published in ‘Cell Reports Methods’ demonstrates the strength of Tagomics’ platform for epigenomic biomarker discovery and applications in liquid biopsyActivace platform enables targeted, genome-wide profiling of unmethylated DNA regions, providing a comprehensive view of the epig...
Building bridges at the Oxford Med-Tech Fair: EFEC’s UK–China life sciences vision
EFEC is laying the foundations of a UK–China Life Sciences Innovation Hub to connect innovators, investors and UK partners. ...
Guardtech support staff member’s epic trek for cancer charity close to the business’ heart
The Haverhill cleanroom construction specialists donated £500 to Sarcoma UK to support their IT & Systems Manager Elliott Sheppard’s 25km trek in honour of his daughter Isobel ...
Miebach Consulting doubles footprint on Abingdon Science Park
Bespoke facilities within The Science Quadrant offer additional capacity as part of ongoing growth ...
Universal drug target potential in scaffolding cells found across the body
Scientists have mapped underappreciated scaffolding cells in skin, known as fibroblasts. They show for the first time how fibroblasts go ‘rogue’ in many different diseases affecting multiple organs – from acne and psoriasis, to rheumatoid arthritis and inflammatory bowel disease. ...
Co-development agreement with US insulin pump device company for AT278 and sale of royalty and technology access fees for up to $11 million
This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR"). Arecor Therapeutics plc(“Arecor” or the “Company”)Co-development Agreement with US Insulin Pump Device Company for AT...
Invent: Life Sciences podcast - make way for advanced therapies – why manufacturing could be coming to a hospital near you
Season 3, Episode 6. In our last episode, we explored the manufacturing strategies that will be key to scaling advanced therapies. Now, we turn our focus to the UK, where new regulatory frameworks and regional collaboration are changing how therapies reach patients. ...
How to solve in-building connectivity issues
Solve in-building wireless challenges without the long timelines.Wilson Connectivity’s Hybrid DAS combines proven amplifier technology with fibre-optic reach, enabling rapid deployment for buildings from 100k to 500k sq ft.The results:Up to 80% faster installation vs. traditional DAS80%...
New IDTechEx Report: Biomanufacturing Specialty Chemicals 2026-2036
IDTechEx's new report "Biomanufacturing Specialty Chemicals 2026-2036" examines the role of white biotechnology in producing specialty chemicals, focusing on food additives, cosmetic and personal care ingredients, pigments, and enzymes. ...
Quantum computing and AI: Synergy or deep tech rivalry?
In this article, IDTechEx explores the fascinating relationship between quantum computing and AI: two supposed tech revolutions that frequently grab the spotlight. Underneath the hype, there exist both technical synergies and competing market forces. ...